Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 -9.062M
April 30, 2026 -9.383M
January 31, 2026 -8.576M
October 31, 2025 -7.213M
July 31, 2025 -6.818M
April 30, 2025 -5.070M
January 31, 2025 -6.012M
October 31, 2024 -5.853M
July 31, 2024 -4.383M
April 30, 2024 -3.376M
January 31, 2024 -3.309M
October 31, 2023 -5.329M
July 31, 2023 -8.174M
April 30, 2023 -15.74M
January 31, 2023 -15.34M
October 31, 2022 -17.25M
July 31, 2022 -15.85M
April 30, 2022 -8.823M
January 31, 2022 -8.145M
October 31, 2021 -4.414M
July 31, 2021 -2.948M
April 30, 2021 -1.610M
January 31, 2021 -0.3777M
October 31, 2020 0.2165M
July 31, 2020 -0.9074M
Date Value
April 30, 2020 -1.428M
January 31, 2020 -2.557M
October 31, 2019 -2.831M
July 31, 2019 -2.999M
April 30, 2019 -2.891M
January 31, 2019 -2.838M
October 31, 2018 -2.722M
July 31, 2018 -2.038M
April 30, 2018 -2.948M
January 31, 2018 -2.940M
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
June 30, 2016
March 31, 2016
December 31, 2015 -0.0028M
September 30, 2015 0.0415M
June 30, 2015 -0.0047M
March 31, 2015 -0.0026M
December 31, 2014 -0.0318M
September 30, 2014 -0.2554M
June 30, 2014 -0.0275M
March 31, 2014 -0.0249M
December 31, 2013 -0.0444M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Repligen Corp. 110.15M
Bio-Techne Corp. 263.22M
BioLife Solutions, Inc. 7.987M
Maravai Lifesciences Holdings, Inc. -35.11M
MaxCyte, Inc. -23.79M